General Proximity
PrivateLast Round
Strategic
Apr 30, 2026
Total Funding Raised
$28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
General Proximity operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Strategic round in April 2026.
General Proximity is a biotechnology company that develops next-generation induced-proximity medicines using its proprietary OmniTAC platform to target previously undruggable proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Proximity Comparables
Compare General Proximity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plexium | 91% | |
| Magnet Biomedicine | 88% | |
| SEED Therapeutics | 88% |
For institutional investors. Book with your work email.
General Proximity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 30, 2026 | ||||
| Seed | Jan 3, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
General Proximity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| age1 | Seed |
| Y Combinator | Seed |
| Wilson Sonsini Goodrich & Rosati | Seed |
| Healthspan Capital | Seed |
| LifeSpan Vision Ventures | Seed |
| Modi Ventures | Seed |
| Felicis Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 72% MoM, reaching 4.2K.
- Apr 30, 2026
Raised capital from Daewoong Pharmaceutical and FreeMind Group.
For institutional investors. Book with your work email.
General Proximity Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about General Proximity's valuation, stock price, and market status.
Is General Proximity a public or private company?
General Proximity is a private company.
What is the current stock price of General Proximity?
General Proximity is a private company, so its shares have no public market price. Caplight tracks General Proximity's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is General Proximity worth (valuation)?
Valuation information for General Proximity is not publicly available.
Can I buy General Proximity stock?
General Proximity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was General Proximity's last funding round?
General Proximity's most recent funding round was Strategic on April 30, 2026.
Who are the main investors in General Proximity?
Key investors in General Proximity include Felicis Ventures.
Will General Proximity IPO soon?
No public IPO plans have been announced for General Proximity.
How can I track General Proximity secondary market activity?
Caplight tracks bids, offers, and trades in General Proximity's shares on secondary markets.